Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

INVITAE CORPORATION

(NVTA)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Invitae: Q1 Earnings Snapshot

05/04/2021 | 05:52pm EDT

SAN FRANCISCO (AP) _ Invitae Corp. (NVTA) on Tuesday reported a loss of $109.5 million in its first quarter.

The San Francisco-based company said it had a loss of 56 cents per share. Losses, adjusted for gains related to mergers and acquisitions, came to 63 cents per share.

The results fell short of Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 60 cents per share.

The genetic testing company posted revenue of $103.6 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $102 million.

Invitae shares have dropped 25% since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $31.50, an increase of 94% in the last 12 months.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on NVTA at https://www.zacks.com/ap/NVTA

Copyright by Automated Insights, Inc. All rights reserved., source Associated Press News

All news about INVITAE CORPORATION
05/06INVITAE  : Morgan Stanley Adjusts Price Target on Invitae to $41 From $45, Maint..
MT
05/05INVITAE  : SVB Leerink Adjusts Invitae's PT to $50 from $65, Keeps Outperform Ra..
MT
05/04INVITAE : Q1 Earnings Snapshot
AQ
05/04INVITAE CORP  : Entry into a Material Definitive Agreement, Change in Directors ..
AQ
05/04INVITAE  : Narrows Q1 Net Loss Following 61% Year-Over-Year Jump in Revenue
MT
05/04INVITAE  : Earnings Flash (NVTA) INVITAE CORPORATION Reports Q1 Revenue $103.6M,..
MT
05/04INVITAE  : Earnings Flash (NVTA) INVITAE CORPORATION Reports Q1 Loss $-0.63, vs...
MT
05/04INVITAE  : Management's Discussion and Analysis of Financial Condition and Resul..
AQ
05/04INVITAE  : Reports $103.6 Million in Revenue Driven by 259,000 in Billable Volum..
PU
05/04INVITAE CORP  : Results of Operations and Financial Condition (form 8-K)
AQ
More news
Financials (USD)
Sales 2021 463 M - -
Net income 2021 -538 M - -
Net Debt 2021 355 M - -
P/E ratio 2021 -10,1x
Yield 2021 -
Capitalization 5 412 M 5 412 M -
EV / Sales 2021 12,4x
EV / Sales 2022 8,73x
Nbr of Employees 2 300
Free-Float 87,8%
Chart INVITAE CORPORATION
Duration : Period :
Invitae Corporation Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends INVITAE CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 8
Average target price 46,50 $
Last Close Price 27,08 $
Spread / Highest target 114%
Spread / Average Target 71,7%
Spread / Lowest Target 47,7%
EPS Revisions
Managers and Directors
NameTitle
Sean Emerson George Chairman, President & Chief Executive Officer
Shelly D. Guyer Chief Financial Officer
Robert Nussbaum Chief Medical Officer
Eric Olivares Chief Science Officer
Layton Wedgeworth Chief Technology Officer
Sector and Competitors
1st jan.Capitalization (M$)
INVITAE CORPORATION-35.23%5 412
EXACT SCIENCES CORPORATION-21.13%17 927
GUARDANT HEALTH, INC.-5.51%13 690
BGI GENOMICS CO., LTD.-9.52%7 412
ADAPTIVE BIOTECHNOLOGIES CORPORATION-45.51%4 909
IOVANCE BIOTHERAPEUTICS, INC.-42.84%4 340